A study by the International Agency for Research on Cancer (IARC) in France has found a new blood test for four protein biomarkers can better identify people who will develop lung cancer in the future.
The study was performed in alliance with the US-based University of Texas MD Anderson Cancer Center.
Researchers measured the blood levels of the tumour-related protein biomarkers in pre-diagnostic samples obtained from a cohort study in the US, to build a risk prediction tool.